Sponsors (2)
The bill strengthens federal demand, domestic preference, and oversight for U.S. biobased products—supporting farmers, manufacturers, and transparency—while risking higher procurement costs, narrower supplier options, and added administrative burdens for agencies.
Small businesses, farmers, and rural communities will see increased federal demand for U.S.-produced biobased products as agencies prioritize domestic biobased purchasing, likely boosting sales, manufacturing, and agricultural feedstock markets.
Policymakers and businesses will get better data (estimated economic value to agriculture and geographic distribution of biomanufacturing), enabling more targeted investment and development of regional biomanufacturing capacity.
Taxpayers and state governments will benefit from increased transparency and accountability because OFPP will publish agency reports and verify compliance in federal procurement of biobased goods.
Taxpayers and state governments could face higher procurement spending if biobased products cost more than conventional alternatives and price preferences do not fully offset those costs.
Procuring agencies and some suppliers may experience narrower supplier pools and higher prices because stricter Buy American and domestic-preference requirements can limit available vendors, risking supply disruptions or reduced competition.
Federal and state agencies will incur additional administrative burdens and costs from new reporting, verification, training, and compliance requirements to meet deadlines and produce expanded reports.
Based on analysis of 2 sections of legislative text.
Strengthens federal biobased procurement by requiring annual increases, adding price and Buy American exceptions, expanding reporting and training, and adding OFPP and GAO oversight.
Introduced September 3, 2025 by Todd Young · Last progress September 3, 2025
Strengthens federal rules for buying biobased products by requiring agencies to increase purchases over time, adding Buy American and price-preference exceptions, expanding reporting and training, and boosting oversight. It requires agencies and the Office of Federal Procurement Policy to track and publish more detailed procurement data, sets deadlines for training and catalog updates, and directs a Comptroller General review within two years to evaluate compliance and data quality. The change aims to promote U.S.-made biobased products and better measure economic benefits to agriculture and biomanufacturing, while allowing agencies to decline purchases that fail Buy American rules or exceed established price preferences. No new funding is specified; several new requirements use deadlines measured from enactment (mostly within two years).